TROP-2–Targeted ADCs for NSCLC: Integrating a New Therapeutic Option

Get up to date on the latest clinical evidence and benefits and nuances of incorporating TROP-2–targeted antibody–drug conjugates into the care of patients with advanced NSCLC by reviewing a CME-certified on-demand webcast and downloadable slides derived from a live symposium, along with a commentary where experts answer frequently asked questions. 

Share

Program Content

Activities

ADCs and TROP-2 in NSCLC
Antibody–Drug Conjugates and the Role of TROP-2 in NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2024

TROP-2 ADCs in NSCLC: Clinical Data
Latest Therapeutic Advancements in Targeting TROP-2 in NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2024

Expires: March 18, 2025

TROP-2 ADCs in NSCLC: Safety
AE Management With TROP-2 ADCs in NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2024

Activities

TROP2 ADCs for NSCLC
TROP-2–Targeted ADCs for NSCLC: ​Integrating a New Therapeutic Option
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 10, 2024

Expires: April 09, 2025

Activities

TROP 2 Targeted ADCs in NSCLC
Mapping TROP-2–Targeted ADCs Into the NSCLC Treatment Landscape
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 02, 2024

Expires: May 01, 2025

Faculty

cover img faculity

Luis Paz-Ares, MD, PhD

Chair of the Medical Oncology Department
Hospital Universitario 12 de Octubre
Associate Professor
Universidad Complutense de Madrid
Head of the Lung Cancer Unit
CNIO (Spanish National Cancer Research Center)
Madrid, Spain

cover img faculity

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Villejuif, France

cover img faculity

Helena Yu, MD

Associate Attending
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.